Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Silco Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,599	1,754	2,533	2,741	2,709	2,325
Market Cap Growth	-30.77%	-30.74%	-7.58%	1.15%	16.52%	0.16%
Enterprise Value	1,580	1,703	2,491	2,643	2,599	2,064
Last Close Price	15.40	16.80	23.94	25.35	24.10	19.78
PE Ratio	34.11	38.24	36.59	32.45	32.01	27.96
PS Ratio	3.73	4.28	5.45	4.90	4.51	3.17
PB Ratio	0.67	0.75	1.09	1.20	1.20	1.03
P/TBV Ratio	0.67	0.75	1.09	1.20	1.20	1.03
P/FCF Ratio	-	32375.63	-	43.53	-	-
P/OCF Ratio	18.34	20.81	14.03	16.21	10.53	15.86
EV/Sales Ratio	3.69	4.15	5.36	4.72	4.32	2.81
EV/EBITDA Ratio	10.21	11.52	16.19	15.35	16.88	11.75
EV/EBIT Ratio	26.30	28.78	37.09	27.12	32.74	21.29
EV/FCF Ratio	-65.89	31423.90	-	41.99	-	-
Debt / Equity Ratio	0.00	0.00	-	0.00	0.00	-
Debt / EBITDA Ratio	0.04	0.06	-	0.02	0.05	-
Debt / FCF Ratio	-	176.56	-	0.07	-	-
Asset Turnover	0.15	0.15	0.17	0.21	0.23	0.28
Inventory Turnover	0.66	0.63	0.71	0.82	0.96	1.19
Quick Ratio	1.49	1.45	1.45	1.56	1.64	2.86
Current Ratio	3.46	3.39	3.40	3.61	3.72	5.10
Return on Equity (ROE)	1.97%	1.96%	3.01%	3.72%	3.75%	3.76%
Return on Assets (ROA)	1.32%	1.32%	1.53%	2.25%	1.85%	2.32%
Return on Capital (ROIC)	1.58%	1.58%	1.82%	2.67%	2.19%	2.74%
Return on Capital Employed (ROCE)	2.40%	2.40%	2.70%	4.00%	3.30%	4.00%
Earnings Yield	2.91%	2.61%	2.73%	3.08%	3.12%	3.58%
FCF Yield	-1.50%	0.00%	-0.06%	2.30%	-4.40%	-1.01%
Dividend Yield	0.66%	0.60%	1.25%	1.97%	4.15%	5.06%
Payout Ratio	14.18%	41.72%	45.43%	74.15%	73.25%	22.11%
Buyback Yield / Dilution	0.62%	-	-	-	-	-28.88%
Total Shareholder Return	1.27%	0.60%	1.25%	1.97%	4.15%	-23.82%

Updated Dec 3, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.